|
GB201204868D0
|
|
Peptides
|
|
WO2012072756A1
|
|
External bone fixator system
|
|
WO2012066141A1
|
|
Markers for acute kidney injury and uses thereof
|
|
WO2012052555A1
|
|
Formulation comprising arginine, use and preparation thereof
|
|
WO2012052953A1
|
|
MiRNA
|
|
WO2012049636A1
|
|
Eif6 phosphorylation antagonists for use in medicine
|
|
GB201114909D0
|
|
Biomarkers for lysosomal storage disorders
|
|
WO2012016963A1
|
|
Peptides for the treatment of brain diseases
|
|
WO2011124652A1
|
|
Immunodominant peptide of polyomavirus jc and uses thereof
|
|
WO2011048054A1
|
|
Evacuation device for fluid exiting an oxygenator of an extracorporeal circulation apparatus
|
|
SG175839A1
|
|
Gene vector
|
|
EP2278332A1
|
|
Method for optical measuring variations of cell membrane conductance
|
|
CA2726231A1
|
|
Uses of conglutin-y
|
|
EP2106803A1
|
|
Method to design and uses of overlapping peptides for monitoring T-cell responses in HIV patients
|
|
WO2008104606A1
|
|
Method for antibody production
|
|
EP2121903A2
|
|
Mitogen independence identifies a highly malignant population of tumor stem cells
|
|
US2008057043A1
|
|
Monocyte cell
|
|
WO2007088050A2
|
|
Method of treatment for muscular dystrophy
|
|
GB0624309D0
|
|
Combination product
|
|
EP1941028A2
|
|
Use of common gamma chain cytokines for the visualization, isolation and genetic modification of memory t lymphocytes.
|
